Skip to main content
SpringerLink
Log in

Single-Photon Scintigraphic Imaging of the Parathyroid Glands: Planar, Tomography (SPECT), and SPECT-CT

  • Chapter
  • First Online:
Medical and Surgical Treatment of Parathyroid Diseases

Abstract

The ability to image the parathyroid glands with scintigraphy, and hyperplastic or adenomatous glands in particular, dates back to 1964 when Potchen and Sodee visualized a parathyroid adenoma using Se-75 selenomethionine in a 31-year-old male suffering from painful bone disease [55]. In the ensuing 45 years, imaging of the parathyroid glands evolved to include the administration of 99m-technetium sestamibi (“MIBI”) followed by a planar scintigraphic technique. Today, the investigation of parathyroid function utilizing three-dimensional tomographic techniques has grown due to the increasing availability of cameras able to reconstruct volumetric data into axial, coronal, and sagittal planes. This technique, single-photon emission tomography (SPECT), has allowed for improved reader confidence in the detection of parathyroid disease largely due to the ability to differentiate overlying structures from abnormal parathyroid glands. Likewise, the increasing availability of hybrid cameras which incorporate both SPECT and computed tomography (CT) has engendered a rush to utilize this hybrid technique (SPECT-CT) for parathyroid localization as it allows for anatomic correlations and localizations that are translatable to a surgical approach. This chapter discusses the current literature regarding the use of planar, SPECT, and SPECT-CT in the evaluation of eutopic and ectopic parathyroid disease, primarily in patients with primary hyperparathyroidism.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hoang JK, Reiman RE, Nguyen GB, Januzis N, Chin BB, Lowry C, Yoshizumi TT. Lifetime attributable risk of cancer from radiation exposure during parathyroid imaging: comparison of 4D CT and parathyroid scintigraphy. Am J Roentgenol. 2015;204(5):W579–85. Basic Science; Level 1; Grade B.

    Article  Google Scholar 

  2. Nichols KJ, Tronco GG, Palestro CJ. Effect of reconstruction algorithm on the accuracy of 99mTc sestamibi SPECT/CT parathyroid imaging. Am J Nucl Med Mol Imaging. 2015;5(2):195–203. Basic Science; Level 1; Grade B.

    CAS  PubMed  PubMed Central  Google Scholar 

  3. Piwnica-Worms D, Kronauge JF, Chiu ML. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence. Circulation. 1990;82(5):1826–38. Basic Science; Level 1; Grade B.

    Article  CAS  PubMed  Google Scholar 

  4. Wong KK, Fig LM, Gross MD, Dwamena BA. Parathyroid adenoma localization with 99mTc-sestamibi SPECT/CT: a meta-analysis. Nucl Med Commun. 2015;36(4):363–75. Clinical Review; Level 1; Grade B.

    Article  CAS  PubMed  Google Scholar 

  5. Hindié E, Zanotti-Fregonara P, Tabarin A, Rubello D, Morelee I, Wagner T, Henry J-F, Taïeb D. The role of radionuclide imaging in the surgical management of primary hyperparathyroidism. J Nucl Med. 2015;56(5):737–44. Clinical Review; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  6. O’Doherty MJ, Kettle AG, Wells P, Collins REC, Coakley AJ. Parathyroid imaging with Technetium-99m-sestamibi: preoperative localization and tissue uptake studies. J Nucl Med. 1992;33(3):313–8. Clinical Investigation; Level 1; Grade B.

    PubMed  Google Scholar 

  7. Otto D, Boerner AR, Hofmann M, Brunkhorst T, Meyer GJ, Petrich T, Scheumann GF, Knapp WH. Pre-operative localization of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur J Nucl Med Mol Imaging. 2004;31(10):1405–12. Clinical Investigation; Level 1; Grade B.

    Article  CAS  PubMed  Google Scholar 

  8. Shafiei B, Hoseinzadeh S, Fotouhi F, Malek H, Azizi F, Jahed A, Hadaegh F, Salehian M, Parsa H, Javadi H, Assadi M. Preoperative 99mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging. Nucl Med Commun. 2012;33(10):1070–6. Clinical Investigation; Level 1; Grade B.

    Article  CAS  PubMed  Google Scholar 

  9. Tang BN, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, Devuyst F, Van Simaeys G, Goldman S. Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging. 2008;3(4):157–63. Clinical Investigation; Level 1; Grade B.

    Article  CAS  PubMed  Google Scholar 

  10. Kim Y, Jung YJ, Hwang KT, Lee H-Y. Efficacy of 99mTc-sestamibi SPECT/CT for minimally invasive parathyroidectomy: comparative study with 99mTc-sestamibi scintigraphy, SPECT. US and CT Ann Nucl Med. 2012;26:804–10. Clinical Investigation; Level 2; Grade A.

    Article  CAS  PubMed  Google Scholar 

  11. Bagul A, Patel HP, Chadwick D, Harrison BJ, Balasubramanian SP. Primary hyperparathyroidism: an analysis of failure of parathyroidectomy. W J Surg. 2014;38(3):534–41. Clinical Investigation; Level 2; Grade B.

    Article  CAS  Google Scholar 

  12. Berner AM, Haroon A, Nowosinska E, Offiah C, Luqman M, Newell M, Jan H. Localization of parathyroid disease with ‘sequential multiphase and dual-tracer’ technique and comparison with neck ultrasound. Nucl Med Commun. 2015;36(1):45–52. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  13. Bleier BS, LiVolsi VA, Chalian AA, Gimotty PA, Bothyl JD, Weber RS. Technetium Tc 99m sestamibi sensitivity in oxyphil cell-dominant parathyroid adenomas. Arch Otolaryngol Head Neck Surg. 2006;132(7):779–82. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  14. Bural GG, Muthukrishnan A, Oborski MJ, Mountz JM. Improved benefit of SPECT/CT compared to SPECT alone for the accurate localization of endocrine and neuroendocrine tumors. Mol Imaging Radionucl Ther. 2012;21(3):91–6. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Cham S, Sepahdari AR, Hall KE, Yeh MW, Harari A. Dynamic parathyroid computed tomography (4DCT) facilitates reoperative parathyroidectomy and enables cure of missed hyperplasia. Ann Surg Oncol. [Internet]. Date of publication [2015 Feb 18];2015 [cited 2015 Jun 8]; http://www.link.springer.com/article/10.1245/s10434-014-4331-0/fulltext.html. Clinical Investigation; Level 2; Grade B.

  16. Chiu B, Sturgeon C, Angelos P. What is the link between nonlocalizing sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy. Surgergy. 2006;140:418–22. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  17. Chroustova D, Kubinyi J, Trnka J, Adamek S. The role of 99m Tc-MIBI SPECT/low dose CT with 3D subtraction in patients with secondary hyperparathyroidism due to chronic kidney disease. Endocr Regul. 2014;48(2):55–63. Clinical Investigation; Level 2; Grade B.

    Article  CAS  PubMed  Google Scholar 

  18. Casara D, Rubello D, Pelizzo MR, Shapiro B. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism. Eur J Nucl Med. 2001;29(9):1351–9. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  19. Cruz de Andrade JS, Mangussi-Gomes JP, Andrade da Rocha L, Ohe MN, Rosano M, Catafesta das Neves M, Santos RDO. Localization of ectopic and supernumerary parathyroid glands in patients with secondary and tertiary hyperparathyroidism: surgical description and correlation with preoperative ultrasonography and Tc99m-sestamibi scintigraphy. Braz J Otorhinolaryngol. 2014;80(1):29–34. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  20. Doruyter AG, Hartley T, Ameyo JW, Davids MR, Warwick JM. Hybrid imaging using low-dose, localizing computed tomography enhances lesion localization in renal hyperparathyroidism. Nucl Med Commun. 2014;35(8):884–9. Clinical Investigation; Level 2; Grade B.

    PubMed  Google Scholar 

  21. Erbil Y, Kapran Y, İsever H, Barbaros U, Adalet I, Dizdaroğlu F, Bozbora A, Özarmağan S, Tezelman S. The positive effect of adenoma weight and oxyphil cell content on preoperative localization with 99mTc-sestamibi scanning for primary hyperparathyroidism. Am J Surg. 2008;195(1):34–9. Clinical Investigation; Level 2; Grade B.

    Google Scholar 

  22. Gayed IW, Kim EE, Broussard WF, Evans D, Lee J, Broemeling LD, Ochoa BB, Moxley DM, Erwin WD, Podoloff DA. The value of 99mRc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J Nucl Med. 2005;46(2):248–52. Clinical Investigation; Level 2; Grade B.

    PubMed  Google Scholar 

  23. Gordon L, Burkhalter W, Mah E. Dual-phase 99mTc-sestamibi imaging: Its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism. J Nucl Med Technol. 2002;30(4):179–84. Clinical Investigation; Level 2; Grade B.

    PubMed  Google Scholar 

  24. Guerin C, Lowery A, Gabriel S, Castinetti F, Phillippon M, Vaillant-Lombard J, Loundou A, Henry JF, Sebag F, Taïeb D. Preoperative imaging for focused parathyroidectomy: making a good strategy even better. Eur J Endocrinol. 2015;172(5):519–26. Clinical Investigation; Level 2; Grade B.

    Article  CAS  PubMed  Google Scholar 

  25. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with 99m-technetium sestamibi scintigraphy. Clin Endocrinol (Oxf). 2002;57(2):241–9. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  26. Harrari A, Mitmaker E, Grogan RH, Lee J, Shen W, Gosnell J, Clark O, Duh QY. Primary hyperparathyroidism in patients with positive preoperative sestamibi scan and negative ultrasound are more likely to have posteriorly located upper gland adenomas (PLUGs). Ann Surg Oncol. 2011;18(6):1717–22. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  27. Heiba SI, Jian M, Rivera J, Genden E, Inabnet W, Machac J, Kostakoglu L. Direct comparison of neck pinhole dual-tracer and dual-phase MIBI accuracies with and without SPECT/CT for parathyroid adenoma detection and localization. Clin Nucl Med. 2015;40(6):476–82. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  28. Herrmann K, Takei T, Kanagae K, Shiga T, Buck AK, Altomonte J, Schwaiger M, Schuster T, Nishijima K, Kuge Y, Tamaki N. Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomas. Mol Imaging Biol. 2009;11(5):3560363. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  29. Katz SC, Wang GJ, Kramer EI, Roses DF. Limitations of technetium 99m sestamibi scintigraphic localization for primary hyperparathyroidism associated with multiglandular disease. Am Surgeon. 2003;69(2):170–5. Clinical Investigation; Level 2; Grade B.

    PubMed  Google Scholar 

  30. Klingensmith WC, Koo PJ, Summerlin A, Fehrenbach BW, Karki R, Shulman EC, Raeburn CD, McIntyre Jr RC. Parathyroid imaging: the importance of pinhole collimation with both single- and dual-tracer acquisition. J Nucl Med Technol. 2013;41(2):99–104. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  31. Lavely WC, Goetze S, Friedman KP, Leal JP, Zhang Z, Garret-Mayer E, Dackiw AP, Turano RP, Zeiger MA, Ziessman HA. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase 99mTc-sestamibi parathyroid scintigraphy. J Nucl Med. 2007;48(7):1084–9. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  32. Lu H-I, Chou F-F, Chi S-Y, Huang S-C. Thoracoscopic removal of hypertrophic mediastinal parathyroid glands in recurrent secondary hyperparathyroidism. W J Surg. 2015;39(2):400–9. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  33. Mandal R, Muthukrishnan A, Ferris RL, de Almeida JR, Duvvuri U. Accuracy of early-phase versus dual-phase single-photon emission computed tomography/computed tomography in the localization of parathyroid disease. Laryngoscope. 2015;125(6):1496–501. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  34. Markovic K, Jankovic MM, Markovic I, Pupic G, Dzodic R, Delaloye AB. Parathyroid dual tracer subtraction scintigraphy: small regions method for quantitative assessment of parathyroid adenoma uptake. Ann Nucl Med. 2014;28(8):736–45. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  35. Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP. Negative imaging studies for primary hyperparathyroidism are unavoidable: Correlation of sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J Surg. 2006;30(5):697–704. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  36. Neumann DR, Obuchowski NA, DiFilippo FP. Preoperative 123I/99mTc-sestabimi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med. 2008;49(12):2012–7. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  37. Ozkaya M, Elboga U, Sahin E, Kalender E, Korkmaz H, Demir HD, Celen YZ, Erkiliç S, Gökalp A, Maralcan G. Evaluation of conventional imaging techniques on preoperative localization in primary hyperparathyroidism. Bosn J Basic Med Sci. 2015;15(1):61–6. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Pata G, Casella C, Besuzio S, Mittempergher F, Salerni B. Clinical appraisal of 99m technetium-sestamibi SPECT/CT compared to conventional SPECT in patients with primary hyperparathyroidism and concomitant nodular goiter. Thyroid. 2010;20(10):1121–7. Clinical Investigation; Level 2; Grade B.

    Article  CAS  PubMed  Google Scholar 

  39. Pata G, Casella C, Magri GC, Lucchini S, Panarotto MB, Crea N, Giubbini R, Salerni B. Financial and clinical implications of low-energy CT combined with 99mTechnetium-sestamibi SPECT for primary hyperparathyroidism. Ann Surg Oncol. 2011;18(9):2555–63. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  40. Patel CN, Salahudeen HM, Lansdown M, Scarsbrook AF. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism. Clin Radiol. 2010;65(4):278–87. Clinical Investigation; Level 2; Grade B.

    Article  CAS  PubMed  Google Scholar 

  41. Roy M, Mazeh H, Chen H, Sippel RS. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg. 2013;37(1):102–6. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  42. Ruf J, Seehofer D, Denecke T, Stelter L, Rayes N, Felix R, Amthauer H. Impact of image fusion and attenuation correction by SPECT-CT on the scintigraphic detection of parathyroid adenomas. Nuklearmedizin. 2007;46(1):15–21. Clinical Investigation; Level 2; Grade B.

    CAS  PubMed  Google Scholar 

  43. Sharma P, Sharma S, Ballal S, Bal C, Malhotra A, Kumar R. SPECT-CT in routine clinical practice: increase in patient radiation dose compared with SPECT alone. Nucl Med Commun. 2012;33(9):926–32. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  44. Slater A, Gleeson FV. Increased sensitivity and confidence of SPECT over planar imaging in dual-phase sestamibi for parathyroid adenoma detection. Clin Nucl Med. 2005;30(1):1–3. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  45. Sugg SL, Krzywda EA, Demeure MJ, Wilson SD. Detection of multiple gland primary hyperparathyroidism in the era of minimally invasive parathyroidectomy. Surg. 2004;136(6):1303–9. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  46. Tee MC, Chan SK, Nguyen V, Strugnell SS, Yang J, Jones S, Tiwari P, Levin DS, Wiserman SM. Incremental value and clinical impact of neck sonography for primary hyperparathyroidism: a risk-adjusted analysis. Can J Surg. 2013;56(6):325–31. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Thomas DL, Bartel TB, Menda Y, Howe J, Graham MM, Juweid ME. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy. Clin Nucl Med. 2009;34(10):651–5. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  48. Tokmak H, Demirkol MO, Alagol F, Tezelman S, Terzioglu T. Clinical impact of SPECT-CT in the diagnosis and surgical management of hyper-parathyroidism. Int J Clin Exp Med. 2014;7(4):1028–34. Clinical Investigation; Level 2; Grade B.

    PubMed  PubMed Central  Google Scholar 

  49. Tunninen V, Varjo P, Schildt J, Ahonen A, Kauppinen T, Lisinen I, Holm A, Eskola H, Seppänen M. Comparison of five parathyroid scintigraphic protocols. Int J Mol Imaging [Internet]. 2013; 12 pp. http://www.hindawi.com/journals/ijmi/2013/921260/. Clinical Investigation; Level 2; Grade B.

  50. Untch BR, Adam MA, Scheri RP, Bennett KM, Dixit D, Webb C, Leight Jr GS, Olson Jr JA. Surgeon-performed ultrasound is superior to 99mTc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 years. J Am Coll Surg. 2011;212(4):522–9. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  51. Vitetta GM, Neri P, Chiecchio A, Carriero A, Cirillo S, Mussetto AB, Codegone A. Role of ultrasonography in the management of patients with primary hyperparathyroidism: retrospective comparison with technetium-99m sestamibi scintigraphy. J Ultrasound. 2014;17(1):1–12. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Witteveen JE, Kievit J, Stokkel MP, Morreau H, Romijn JA, Hamdy NA. Limitations of Tc99m-MIBI-SPECT imaging scans in persistent primary hyperparathyroidism. World J Surg. 2011;35:128–30. Clinical Investigation; Level 2; Grade B.

    Article  PubMed  Google Scholar 

  53. Yang J, Hao R, Yuan L, Li C, Yan J, Zhen L. Value of dual-phase (99m)Tc-sestamibi scintigraphy with neck and chest SPECT/CT in secondary hyperparathyroidism. Am J Roentgenol. 2014;202(1):180–4. Clinical Investigation; Level 2; Grade B.

    Article  Google Scholar 

  54. Suh YJ, Choi JY, Kim S, Chun IK, Yun TJ, Lee KE, Kim J, Cheon GJ, Youn Y-K. Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism. Otolaryngol Head Neck Surg. 2015;152(3):438–43. Clinical Investigation; Level 4.

    Article  PubMed  Google Scholar 

  55. Potchen EJ, Sodee DB. Selective isotopic labeling of the human parathyroid: a preliminary case report. J Clin Endocrinol Metab. 1964;24:1125–8. Case Report; Level 4.

    Article  CAS  PubMed  Google Scholar 

  56. Balon HR, Silberstein EB, Meier DA, Charles ND, Sarkar SD, Royal HD, Donohoe KJ. Society of nuclear medicine procedure guideline for thyroid scintigraphy. V 3.0. 2006. Professional Society Guideline; Level 5.

    Google Scholar 

  57. Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O’Doherty M, Palestro CJ, Scheve W, Stabin MG, Sylvestros D, Tulchinsky M. SNM practice guideline for parathyroid scintigraphy 4.0. J Nucl Med Technol. 2012;40(2):111–8. Professional Society Guideline; Level 5.

    Article  PubMed  Google Scholar 

  58. Greenspan BS, Pucar D, Gelfand MJ, Grant FD, Mandell GA, Sharp SE. ACR-SPR practice parameter for the performance of scintigraphy and uptake measurements for benign and malignant thyroid disease. Revised 2014 (Resolution 33). Professional Society Guideline; Level 5.

    Google Scholar 

  59. Hindié E, Ugur Ő, Fuster D, O’Doherty M, Grassetto G, Ureña P, Kettle A, Gulee SA, Pons F, Rubello D. 2009 EANM parathyroid guidelines. Eur J Nucl Med Mol Imaging. 2009;36(7):1201–6. Professional Society Guideline; Level 5.

    Article  PubMed  Google Scholar 

  60. Kukora JS, Zeiger MA, Clark OH, Grant CS, Hodgson SF, Irvin III GL, Kleerekoper M, Pasieka JL, Shah AR, Thompson GB, van Heerden JA, Weber CJ, The American Association of Clinical Endocrinologists and the American Association of Endocrine Surgeons Position Statement on the Diagnosis and Management of Primary Hyperparathyroidism. AACE/AAES Task Force on Primary Hyperparathyroidism. Endocr Pract. 2005;11(1):49–54. Professional Society Guideline; Level 5.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Physiology, George Washington University School of Medicine and Health Sciences, 2300 Eye St. NW, Ross Hall Room 640, Washington, DC, 20037, USA

    Tracy L. Yarbrough M.D., Ph.D.

  2. Global Advanced Imaging, PLLC, Little Rock, AR, 72223, USA

    Twyla B. Bartel

  3. Department of Otolaryngology-Head an Neck Surgery, University of Arkansas for Medical Sciences, 4301 W. Markham St., Little Rock, AR, 72205, USA

    Brendan C. Stack Jr.

Authors
  1. Tracy L. Yarbrough M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Twyla B. Bartel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brendan C. Stack Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tracy L. Yarbrough M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Department of Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

    Brendan C. Stack, Jr.

  2. Department of Geniatrics and Otolaryngology-Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

    Donald L. Bodenner

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Yarbrough, T.L., Bartel, T.B., Stack, B.C. (2017). Single-Photon Scintigraphic Imaging of the Parathyroid Glands: Planar, Tomography (SPECT), and SPECT-CT. In: Stack, Jr., B., Bodenner, D. (eds) Medical and Surgical Treatment of Parathyroid Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-26794-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-26794-4_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-26792-0

  • Online ISBN: 978-3-319-26794-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation